Lepu Biopharma Co., Ltd.'s (HKG:2157) Low P/S No Reason For Excitement

Simply Wall St.02-11

With a price-to-sales (or "P/S") ratio of 11.1x Lepu Biopharma Co., Ltd. (HKG:2157) may be sending bullish signals at the moment, given that almost half of all the Biotechs companies in Hong Kong have...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2610778026?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","is_english":true,"pubTime":"2026-02-11 06:10","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2610778026","market":"us","top_or_hot":-1,"title":"Lepu Biopharma Co., Ltd.'s (HKG:2157) Low P/S No Reason For Excitement","media":"Simply Wall St.","content":"<div>\n<p>With a price-to-sales (or \"P/S\") ratio of 11.1x Lepu Biopharma Co., Ltd. (HKG:2157) may be sending bullish signals at the moment, given that almost half of all the Biotechs companies in Hong Kong have...</p>\n\n<a href=\"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2157/lepu-biopharma-shares/news/lepu-biopharma-co-ltds-hkg2157-low-ps-no-reason-for-exciteme\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Lepu Biopharma Co., Ltd.'s (HKG:2157) Low P/S No Reason For Excitement</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLepu Biopharma Co., Ltd.'s (HKG:2157) Low P/S No Reason For Excitement\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-02-11 06:10 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2157/lepu-biopharma-shares/news/lepu-biopharma-co-ltds-hkg2157-low-ps-no-reason-for-exciteme><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>With a price-to-sales (or \"P/S\") ratio of 11.1x Lepu Biopharma Co., Ltd. (HKG:2157) may be sending bullish signals at the moment, given that almost half of all the Biotechs companies in Hong Kong have...</p>\n\n<a href=\"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2157/lepu-biopharma-shares/news/lepu-biopharma-co-ltds-hkg2157-low-ps-no-reason-for-exciteme\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1161","symbol_name":"生物科技","start_time":0,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2157/lepu-biopharma-shares/news/lepu-biopharma-co-ltds-hkg2157-low-ps-no-reason-for-exciteme","article_id":"2610778026","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2157/lepu-biopharma-shares/news/lepu-biopharma-co-ltds-hkg2157-low-ps-no-reason-for-exciteme","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2610778026","pubTimestamp":1770761455,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"With a price-to-sales (or \"P/S\") ratio of 11.1x Lepu Biopharma Co., Ltd. ( HKG:2157 ) may be sending bullish signals at...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK1161":"生物科技","02157":"乐普生物-B"},"translate_title":"乐普生物制药有限公司（HKG：2157）市盈率低，无需兴奋","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"91348":1.5,"02157":1.5},"content_text":"With a price-to-sales (or \"P/S\") ratio of 11.1x Lepu Biopharma Co., Ltd. (HKG:2157) may be sending bullish signals at the moment, given that almost half of all the Biotechs companies in Hong Kong have P/S ratios greater than 13.8x and even P/S higher than 76x are not unusual.   However, the P/S might be low for a reason and it requires further investigation to determine if it's justified.    AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.  See our latest analysis for Lepu Biopharma SEHK:2157 Price to Sales Ratio vs Industry February 10th 2026Advertisement How Lepu Biopharma Has Been Performing  With revenue growth that's superior to most other companies of late, Lepu Biopharma has been doing relatively well.   It might be that many expect the strong revenue performance to degrade substantially, which has repressed the share price, and thus the P/S ratio.  If you like the company, you'd be hoping this isn't the case so that you could potentially pick up some stock while it's out of favour.      If you'd like to see what analysts are forecasting going forward, you should check out our free report on Lepu Biopharma.  Do Revenue Forecasts Match The Low P/S Ratio?   There's an inherent assumption that a company should underperform the industry for P/S ratios like Lepu Biopharma's to be considered reasonable.   Taking a look back first, we see that the company grew revenue by an impressive 242% last year.    Still, revenue has barely risen at all from three years ago in total, which is not ideal.  Therefore, it's fair to say that revenue growth has been inconsistent recently for the company.     Looking ahead now, revenue is anticipated to climb by 10% during the coming year according to the dual analysts following the company.  That's shaping up to be materially lower than the 647% growth forecast for the broader industry.  With this in consideration, its clear as to why Lepu Biopharma's P/S is falling short industry peers.  Apparently many shareholders weren't comfortable holding on while the company is potentially eyeing a less prosperous future.    The Key Takeaway  We'd say the price-to-sales ratio's power isn't primarily as a valuation instrument but rather to gauge current investor sentiment and future expectations.  As we suspected, our examination of Lepu Biopharma's analyst forecasts revealed that its inferior revenue outlook is contributing to its low P/S.  Shareholders' pessimism on the revenue prospects for the company seems to be the main contributor to the depressed P/S.  Unless these conditions improve, they will continue to form a barrier for the share price around these levels.      Having said that, be aware Lepu Biopharma is showing 2 warning signs in our investment analysis, and 1 of those is a bit concerning.   Of course, profitable companies with a history of great earnings growth are generally safer bets. So you may wish to see this free collection of other companies that have reasonable P/E ratios and have grown earnings strongly. New: AI Stock Screener & AlertsOur new AI Stock Screener scans the market every day to uncover opportunities.• Dividend Powerhouses (3%+ Yield)• Undervalued Small Caps with Insider Buying• High growth Tech and AI CompaniesOr build your own from over 50 metrics.Explore Now for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2610778026","isCrawlerRequest":true}